Delivery Order SPE2DB20D9329-SPE2DB23FZM05
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $91,598.40 contract is for the delivery of Cabometyx 20 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,221.97 contract was awarded by the Defense Logistics Agency (DLA) to supply the drug CABOMETYX 40 MG TABLET 30S. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products for military health facilities...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Department of Defense (DoD) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $15,409.02, is for the delivery of Cabometyx 40 mg tablets to meet the recurring pharmaceutical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) on September 17, 2025, with completion targeted for September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,632.54 contract is for the delivery of 4567008408 - CABOMETYX 20 MG TABLET 30S, a prescription drug product, with a period of performance through January 23, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,434.34 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Cabometyx 60 mg tablets (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of September 19, 2025, represents a single pharmaceutical product delivery under the company's existing indefinite delivery contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,596.22, is for the delivery of Cabometyx 20 mg tablets. The order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order, contract SPE2DB24FSW72, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $15,409.02 order is for the supply of Cabometyx 40 mg tablets. This delivery order is part of a larger indefinite-delivery vehicle (IDV), contract SPE2DB22D9367, with DMS Pharmaceutical Group that has a ceiling value of up to $4,999,999 through 2025. The IDV allows DLA to issue delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $33,000 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that enables the agency to...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB23FZM05Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,221.97, is for the supply of the drug Cabometyx 40mg tablets. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 9/19/23 |